Bendamustine

Bendamustine is used in the treatment of chronic lymphocytic leukemia (type of cancer that starts from white blood cells in the bone marrow), non-Hodgkin’s lymphomas failed treatment with rituximab and multiple myeloma (cancer that forms in plasma cell) in combination with prednisone.